SEE FAR CBT Intervention for Adults With PTSD
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: SEE FAR CBT.
- Who it may be relevant to
- Registry conditions: Post Traumatic Stress Disorder. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Israel
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Clinical Study Evaluating the Effects of a SEE FAR CBT Intervention on Psychological Outcomes in Adults With Posttraumatic Stress Disorder.
Overview
This single-arm clinical intervention study evaluates a 12-session SEE FAR CBT intervention for adults aged 18 years and older with posttraumatic stress disorder (PTSD). SEE FAR CBT is a trauma-focused cognitive-behavioral treatment approach. Participants will complete self-report psychological questionnaires at three time points: baseline, after completion of the intervention, and at a 3-month follow-up. The study aims to examine changes in PTSD symptoms and related psychological outcomes over the course of treatment and follow-up.
Interventions
- Behavioral SEE FAR CBT
SEE FAR CBT is a trauma-focused cognitive-behavioral treatment approach. Participants will receive 12 therapeutic sessions delivered approximately once weekly as a structured psychological intervention for PTSD.
Primary outcome measures
- Change in PTSD symptoms [Time frame: Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention]
- Change in anxiety symptoms [Time frame: Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention]
Secondary outcome measures (5)
- Change in depressive symptoms [Time frame: Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention]
- Change in perceived stress [Time frame: Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention]
- Change in resilience [Time frame: Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention]
- Change in somatic symptoms [Time frame: Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention]
- Change in trauma-related use of imagination and coping [Time frame: Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention]
Eligibility criteria
Inclusion criteria
Participants must meet all of the following criteria:
- Age 18 years or older
- PTSD symptoms, defined as a PCL-5 score of 30 or above
- Able to provide informed consent
- Willing and able to participate in 12 weekly individual therapy sessions and complete study questionnaires at baseline, post-intervention, and 3-month follow-up Exclusion Criteria
Participants will be excluded if they meet any of the following criteria:
- Pregnancy at the time of enrollment, due to the potential influence of pregnancy and childbirth during the treatment or follow-up period on psychological outcomes.
- Currently receiving psychotherapy of any type that began less than 3 months prior to enrolment.
- Initiation of psychiatric medication less than 3 months prior to enrolment.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Israel · 1 center
- Community Stress Prevention Center — Kiryat Shmona
Identifiers
NCT: NCT07720674 · SEE-FAR-CBT-PTSD-NORTH-2026